Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for Allergan Inc., dated March 20, 1998.


--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-

Published Date:   March 20, 1998

Company Name:     Allergan Inc.

Address:          2525 Dupont Dr.
                  Irvine, Calif. 92612

Main Telephone
 Number:          714/246-4500

Internet Home
 Page Address
  (URL):          www.allergan.com

Chief Executive
 Officer:         David Pyott

Investor Relations
 Contact:         Joyce Jameson
 Business number: 714/246-5541

Trading Symbol/
 Exchange:        NYSE:AGN

Industry:         pharmaceutical





Company description: Allergan is a technology-driven, global health-care company focused on specialty pharmaceutical products for specific disease areas that deliver value to customers, satisfy unmet medical needs and improve patients' lives. Allergan's yearly sales exceed $1 billion, and the company employs more than 6,000 technology and customer focused individuals in more than 100 countries around the world. Principal research facilities are located at corporate headquarters in Irvine, Calif.

Devoting more than 10% of its sales to research and development, Allergan seeks to use proprietary technology to develop unique pharmaceutical products that create value and achieve a sustainable competitive advantage. R&D efforts are focused in the disease areas of glaucoma/neuroprotection, retinal retinal /ret·i·nal/ (ret´i-n'l)
1. pertaining to the retina.

2. the aldehyde of retinol, derived from absorbed dietary carotenoids or esters of retinol and having vitamin A activity.
 disease, cataracts Cataracts Definition

A cataract is a cloudiness or opacity in the normally transparent crystalline lens of the eye. This cloudiness can cause a decrease in vision and may lead to eventual blindness.
 and dry eye; skin disorders such as psoriasis psoriasis (sôrī`əsĭs), occasionally acute but usually chronic and recurrent inflammation of the skin. The exact cause is unknown, but the disease appears to be an inherited, possibly autoimmune disorder that causes the , acne acne, common inflammatory disease of the hair follicles and sebaceous glands characterized by blackheads, whiteheads, pustules, nodules and, in the more severe forms, by cysts and scarring. The lesions appear on the face, neck, back, chest, and arms.  and photo-damaged skin; and other diseases such as movement disorders Movement Disorders Definition

Movement disorders are a group of diseases and syndromes affecting the ability to produce and control movement.
Description
, pain and cancer.

Founded in 1948, Allergan became a public company in 1970, merged with SmithKline Beckman in 1980, and was reestablished as an independent entity in 1989. Allergan common stock is traded on the New York Stock Exchange New York Stock Exchange (NYSE)

World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City.
 under the symbol AGN AGN Again (Amateur Radio)
AGN Active Galactic Nucleus
AGN Acute Glomerulonephritis
AGN Accountants Global Network
AGN Air Gabon (ICAO code) 
. (52-week high/low: 37-3/16 / 25-7/8)

Allergan releases are available on Allergan's Corporate News on the Net site at http://www.businesswire.com/cnn/agn.htm.

CONTACT: Allergan Inc.
COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 20, 1998
Words:299
Previous Article:Corporate Profile for Anchor Financial Corp., dated March 20, 1998.
Next Article:Corporate Profile for Travelogix Inc., dated March 20, 1998.
Topics:



Related Articles
Allergan Board adopts guidelines on significant Corporate Governance Issues; Tamara J. Erickson named to chair the Corporate Governance Committee.
Allergan Reports First Quarter Results.
Allergan Announces Corporate Restructuring Plan; Special Charges of Approximately $103 Million for Work Force Reductions, Plant Consolidations and...
Corporate Profile for Allergan Inc., dated Friday, Dec. 18., 1998.
Allergan's ALOCRIL Receives FDA Marketing Approval for Treatment of Allergic Conjunctivitis.
Allergan In-Licenses Novel Compound for the Treatment of Ocular Allergy From Boehringer Ingelheim.
Allergan Specialty Therapeutics, Inc. Reports First Quarter Results.
Pyott's Voyage in Lilliput.
Allergan, Inc. Exercises Option to Purchase Class A Common Stock of Allergan Specialty Therapeutics, Inc.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles